Compugroup Medical (Germany) Performance
| COP Stock | EUR 16.19 0.40 2.53% |
Compugroup Medical has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Compugroup Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Compugroup Medical is expected to be smaller as well. Compugroup Medical right now shows a risk of 2.56%. Please confirm Compugroup Medical standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to decide if Compugroup Medical will be following its price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Compugroup Medical SE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Compugroup Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 75.9 M | |
| Total Cashflows From Investing Activities | -164 M |
Compugroup |
Compugroup Medical Relative Risk vs. Return Landscape
If you would invest 1,511 in Compugroup Medical SE on August 31, 2024 and sell it today you would earn a total of 68.00 from holding Compugroup Medical SE or generate 4.5% return on investment over 90 days. Compugroup Medical SE is currently producing 0.1007% returns and takes up 2.555% volatility of returns over 90 trading days. Put another way, 22% of traded stocks are less volatile than Compugroup, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Compugroup Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugroup Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Compugroup Medical SE, and traders can use it to determine the average amount a Compugroup Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0394
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | COP | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.56 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Compugroup Medical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compugroup Medical by adding it to a well-diversified portfolio.
Compugroup Medical Fundamentals Growth
Compugroup Stock prices reflect investors' perceptions of the future prospects and financial health of Compugroup Medical, and Compugroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compugroup Stock performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.74 B | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 35.30 X | |||
| Price To Book | 2.99 X | |||
| Price To Sales | 1.76 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 213.99 M | |||
| Cash And Equivalents | 44.29 M | |||
| Cash Per Share | 0.91 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 132.20 % | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.36 X | |||
| Total Asset | 1.79 B | |||
About Compugroup Medical Performance
By analyzing Compugroup Medical's fundamental ratios, stakeholders can gain valuable insights into Compugroup Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Compugroup Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Compugroup Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany. COMPUGROUP MED operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5000 people.Things to note about Compugroup Medical performance evaluation
Checking the ongoing alerts about Compugroup Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compugroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Compugroup Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Compugroup Medical SE has accumulated 587.08 M in total debt with debt to equity ratio (D/E) of 132.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Compugroup Medical has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Compugroup Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Compugroup Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Compugroup Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Compugroup to invest in growth at high rates of return. When we think about Compugroup Medical's use of debt, we should always consider it together with cash and equity. | |
| About 50.0% of Compugroup Medical shares are held by company insiders |
- Analyzing Compugroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compugroup Medical's stock is overvalued or undervalued compared to its peers.
- Examining Compugroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Compugroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compugroup Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Compugroup Medical's stock. These opinions can provide insight into Compugroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Compugroup Stock analysis
When running Compugroup Medical's price analysis, check to measure Compugroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugroup Medical is operating at the current time. Most of Compugroup Medical's value examination focuses on studying past and present price action to predict the probability of Compugroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugroup Medical's price. Additionally, you may evaluate how the addition of Compugroup Medical to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |